Denali Therapeutics Inc. · NASDAQ:DNLI
Schenkein David P received 6,408 Denali Therapeutics Inc. shares as an award (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, Schenkein David P (Director) received 6,408 Denali Therapeutics Inc. shares as an award, leaving 21,665 shares. Filed Jun 5, 2026 (Form 4).
- Awarded
- 6,408 shares
- Holding after
- 21,665 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Award | 6,408 | 21,665 | Direct |